During the past decade, Florida Cancer Specialists North conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 32 clinical trials were completed, i.e. on average, 60.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 18 clinical trials were completed. i.e. 105.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cancer Specialists North" #1 sponsor was "SCRI Development Innovations, LLC" with 20 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Novartis Pharmaceuticals" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Odonate Therapeutics, Inc." with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists North" #1 collaborator was "Novartis" with 6 trials as a collaborator, "GlaxoSmithKline" with 4 trials as a collaborator, "Achieve Life Sciences" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists North" are "Breast Cancer" (7 trials), "Multiple Myeloma" (4 trials), "Gastric Cancer" (3 trials), "Gastroesophageal Junction Adenocarcinoma" (3 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Florida Cancer Specialists North" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialists North" are "Drug" (63 trials), "Biological" (6 trials), "Other" (3 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Gemcitabine" (6 trials), "Nivolumab" (5 trials), "Atezolizumab" (4 trials) and "Capecitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialists North" are 58 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Cancer Specialists North". undefined are not yet recruiting, 10 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Florida Cancer Specialists North, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialists North, 15 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".